Cathie Wooden’s Ark Make investments Offloads Uipath, Prime Drugs, And Repare Therapeutics – ARK Genomic Revolution ETF (BATS:ARKG), ARK Innovation ETF (BATS:ARKK)

On Friday, April 11, 2025, Cathie Wooden-led Ark Make investments executed notable trades, shedding shares in UiPath Inc. PATH, Prime Drugs Inc. PRME, and Repare Therapeutics Inc. RPTX.

The PATH Commerce

Ark Make investments’s ARK Innovation ETF ARKK fund bought 4,256 shares of UiPath Inc. Based mostly on the closing value of $10.87 on the day of the commerce, the whole worth of the transaction quantities to roughly $46,280.32.

UiPath’s inventory noticed a slight improve of two.26% on the day.

The PRME Commerce

Prime Drugs Inc. was one other firm that Ark Make investments determined to scale back its stake in. The ARKK fund bought 83,510 shares of PRME. With the inventory closing at $1.33 on the day of the commerce, the worth of the bought shares is round $111,068.30.

Curiously, PRME’s inventory skilled a big surge of 13.68% on the commerce day.

See Additionally: JPMorgan CEO Jamie Dimon Expects S&P 500 Development Forecast To Be Reduce

The RPTX Commerce

Ark Make investments’s Ark Genomic Revolution ETF ARKG fund offloaded shares of Repare Therapeutics Inc. The fund bought 130,611 shares of RPTX. Given the closing value of $0.9 on the commerce day, the whole worth of the transaction is roughly $117,549.90. The inventory’s value remained unchanged on the day of the commerce.

These trades come within the wake of Ark Make investments’s earlier transactions, which featured outstanding purchases of Tempus AI Inc and Coinbase World Inc shares amid a pointy market selloff triggered by financial uncertainty and a 145% China tariff announcement by the Trump administration.

Learn Subsequent:

Disclaimer: This content material was partially produced with the assistance of AI instruments and was reviewed and revealed by Benzinga editors.

Photograph courtesy: Shutterstock